AMORPHOUS AND CRYSTALLINE FORMS OF LOSARTAN POTASSIUM AND PROCESS FOR THEIR PREPARATION

This invention relates to novel amorphous losartan potassium, novel losartan potassium in a crystalline form that is a hydrate, novel crystalline losartan potassium Form IV and solvates thereof; novel crystalline losartan potassium Form V and solvates thereof, to processes for their preparation, to compositions containing them and to their use in medicine. This invention further relates to a novel process for preparing crystalline losartan potassium Form I and Form II.

BUSINESS AT 5 BASEL STREET, P.O. BOX 3190, PETAH TIQVA 49131, ISRAEL. Israel

TEVA PHARMACEUTICAL INDUSTRIES, LTD.

01286/DELNP/2004 A

1286/DELNP/2004

INDIA

2009-03-20T11:47:49Z

2007-01-19

2004-05-13

319843

2002-11-13

PCT/US02/36550

C07D 257/04

WO 03/048135

BEN ZION DOLITZKY, SHLOMIT WIZEL, GENNADY NISNEVICH, IGOR RUKHMAN, JULIA KAFTANOV

1063

U.S.A.

2001-11-14

60/333,034

2007-01-19

AMORPHOUS AND CRYSTALLINE FORMS OF LOSARTAN POTASSIUM AND PROCESS FOR THEIR PREPARATION ZnRNZAz

2009-04-30T18:40:56Z

87792 BEN ZION DOLITZKY, SHLOMIT WIZEL, GENNADY NISNEVICH, IGOR RUKHMAN, JULIA KAFTANOV 3597 TEVA PHARMACEUTICAL INDUSTRIES